Werfen ha compartido esto
We Venture Capital is pleased to announce its investment into Proton Intelligence in a heavily oversubscribed $6.95m Seed round alongside Tenmile, SOSV, LongeVC, 15th Rock, Exor Ventures, Trampoline Venture Partners and others. The company is developing the world´s first non invasive CKM™ for monitoring potassium levels of kidney patients. 1/3 of patients with chronic kidney disease or heart failure unnecessarily stop life-saving therapy after a high potassium event, which ultimately leads to a c.40% increase in 6-month mortality. Proton’s CKM™ technology aims to provide providers and patients accurate, remote, continuous potassium levels allowing precise treatment of these patients. “We Venture Capital have been impressed by this true breakthrough in electrolyte sensing capability, which will fulfil a critical gap in the current care continuum for many patients at risk from dyskalemia. We look forward to working with the Proton Intelligence team on the next phase of their journey” said Dr. Louise Warme, Head of We Venture Capital. Congratulations to Sahan Ranamukhaarachchi, Víctor J. Cadarso and the Proton Intelligence team! About Proton Intelligence 👉 https://lnkd.in/eVCwZ6Xu About We Venture Capital 👉 https://lnkd.in/eyvXpGZ4 CC: Louise Warme Anthony Vallance-Owen Gökçe Gün, MD MBA Richa Goswami Rory St Clair Gemma Sturt #healthcare #Seedround #VC #diagnostics #venturecapital #startups #fundraising